Clinical Trial Update: Efficacy and Safety of VER-01 in the Treatment of Patients With Chronic Non-specific Low Back Pain [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating VER-01 for chronic non-specific low back pain has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-specific Low Back Pain

Drugs mentioned

• VER-01 (VER-01)

Snippet

Sponsor: Vertanical GmbH | Conditions: Chronic Non-specific Low Back Pain | Phase 3 | Status: COMPLETED